Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
34%
OVERLAP
BY WEIGHT
55
# OF OVERLAPPING
HOLDINGS
IBB
251
HOLDINGS
25%
ALSO IN BBP
BBP
70
HOLDINGS
89%
ALSO IN IBB
SECTOR DRIFT (IBB minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
| MODERNA, INC. | 1.5% | 1.9% | 1.5% | |
| VERTEX PHARMACEUTICALS INC | 7.8% | 1.5% | 1.5% | |
| REGENERON PHARMACEUTICALS | 5.2% | 1.4% | 1.4% | |
| ROIVANT SCIENCES LTD. | 1.4% | 1.5% | 1.4% | |
| ALNYLAM PHARMACEUTICALS INC | 2.8% | 1.4% | 1.4% | |
IBB Overweight Relative to BBP
| AMGEN INC | 6.8% | |
| VERTEX PHARMACEUTICALS INC | 6.4% | |
| GILEAD SCIENCES INC | 5.7% | |
| REGENERON PHARMACEUTICALS | 3.8% | |
| ARGENX SE ADR | 3.8% | |
| REVOLUTION MEDICINES, INC. | 2.8% | |
| NATERA INC | 2.8% | |
| ILLUMINA INC | 2.3% | |
| ALNYLAM PHARMACEUTICALS INC | 1.4% | |
| GENMAB A/S SPONSORED ADR | 1.2% |
IBB Underweight Relative to BBP
| OMEROS CORP | -1.7% | |
| TG THERAPEUTICS INC | -1.5% | |
| LIGAND PHARMACEUTICALS-CL B | -1.5% | |
| ARDELYX INC | -1.5% | |
| SAREPTA THERAPEUTICS INC | -1.5% | |
| AGIOS PHARMACEUTICALS INC | -1.5% | |
| GERON CORP | -1.5% | |
| KURA ONCOLOGY, INC. | -1.5% | |
| NUVATION BIO INC CLASS A | -1.5% | |
| INTREXON CORP | -1.5% |